Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma

T Takafumi Fukushima K Kazuyuki Numakura M Masanao Shinohara Y Yohei Kawashima Y Yuya Sekine K Kanami Mori M Mizuki Kobayashi H Himawari Asanuma T Takaki Ichiyama H Hisashi Sakurai K Kai Ozaki N Naoki Fujita T Teppei Okamoto H Hayato Yamamoto T Takahiro Yoneyama S Satoshi Sato T Tomonori Habuchi C Chikara Ohyama S Shingo Hatakeyama

Article Details

Volume / Issue Vol. 15, Issue 1
Published July 18, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (19)

T

Takafumi Fukushima

K

Kazuyuki Numakura

M

Masanao Shinohara

Y

Yohei Kawashima

Y

Yuya Sekine

K

Kanami Mori

M

Mizuki Kobayashi

H

Himawari Asanuma

T

Takaki Ichiyama

H

Hisashi Sakurai

K

Kai Ozaki

N

Naoki Fujita

T

Teppei Okamoto

H

Hayato Yamamoto

T

Takahiro Yoneyama

S

Satoshi Sato

T

Tomonori Habuchi

C

Chikara Ohyama

S

Shingo Hatakeyama